The industry has been given just a few days to review and provide feedback on guidelines for the new 25 per cent statutory price cut that many believe do not match the intent of the Medicines Australia strategic agreement. …
Latest Video
New Stories
-
AstraZeneca confirms pricing the issue, and acts to create a patient access program
June 16, 2026 - - Latest News -
When good policy becomes self defeating, Australia must at least have a discussion about the obvious solution
June 16, 2026 - - Latest News -
Entropy Neurodynamics clears safety hurdle for IV psilocin trial in binge eating disorder
June 15, 2026 - - Australian Biotech -
Paradigm reaches global milestone as Phase 3 osteoarthritis trial completes enrolment
June 15, 2026 - - Australian Biotech -
The 'Dispatched' Week in Review'- 14 June
June 15, 2026 - - Podcast -
Approach policy and pricing negotiations like planning for a product launch
June 15, 2026 - - Latest News -
High Court to decide on patent‑term extensions for formulations as GBMA intervenes
June 15, 2026 - - Latest News